|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/117 | (2010.01) |
| A61K 31/70 | (2006.01) | ||
| A61K 8/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 2405002 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11183857.9 |
| Europos patento paraiškos padavimo data | 2007-02-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-01-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-09-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 773505 P | 2006-02-15 | US | |
| 858240 P | 2006-11-09 | US |
| (72) |
Uhlmann, Eugen, DE
Vollmer, Joerg, DE
Krieg, Arthur M., US
Samulowitz, Ulrike, DE
Noll, Bernhard, DE
|
| (73) |
AdiuTide Pharmaceuticals GmbH,
Alt Fechenheim 34, 60386 Frankfurt am Main,
DE
|
| (54) | Compositions and methods for oligonucleotide formulations |
| Compositions and methods for oligonucleotide formulations |